Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major playersรขโฌโข financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The market for musculoskeletal system disorder treatments is significantly influenced by the rising prevalence of these disorders, particularly among the aging population. As people age, the likelihood of developing conditions such as osteoarthritis, rheumatoid arthritis, and osteoporosis increases, driving the demand for effective therapies.
Innovations in medical technology paved way for the market topography. With regard to that, advances in diagnostics equipment and imaging technologies as well minimally transferred surgeries are those factors which facilitate quicker diagnoses and higher effectiveness of treatment results. Such innovations are appealing to the providers of healthcare together with patients, promoting market development respectively.
Research and development activities persist in the pharmaceutical sector leading to widening of treatment alternatives for musculoskeletal disorders. The availability of new drugs, biologics and targeted therapies presents the patients with more options ultimately benefiting research driven pharmaceutical companies to compete in this market evolution.
Market availability of musculoskeletal disorders state directly depends on the development level of healthcare infrastructure in different regions. In areas that have well developed health systems, adoption would be higher for advanced treatments and surgical interventions; further differences in access to medicare also bring variations into the market.
What takes the form of global economic conditions impact on musculoskeletal disorder market. A stable economic environment can lead to increased healthcare spending, thus making it possible for the highly innovative methods being incorporated. On the other hand, economic recession might restrict healthcare budgets which in turn influence patient affordability and market dynamics.
Empowerment of patient on musculoskeletal disorders and treatment options is a major market accelerator. Educational approaches as well an awareness campaigns leads to the early detection and proactive approach. They affect patient preferences, demands for certain treatments etc
The scope of insurance coverage in musculoskeletal disorder treatments deeply impacts the market trends. Therefore, all-inclusive medical insurance that includes diagnostics, therapies and surgeries which means better access to more treatments will lead to an improved picture for market growth.
Changing the lifestyle such as sedentary habits and poor quality of food added to increase musculoskeletal disorders. The market responds to these, lifestyle trends with preventive approach both medic as well medical non-medic insights complemented by the rehabilitation services and lifestyle interventions.
The market also responds to strict drug approval regulations, medical device rules as well prescriptions. Conformity to regulatory standards ensures the safety and effectiveness of musculoskeletal disorder treatments; efficient market entry procedure benefits high-performing innovative therapies.
Alliances between drug-manufacturing companies, healthcare professionals and health research organizations are helpful in the knowledge transfer as well bedrive innovation. The adoption of partnerships can be seen as a great contributor to the development into effective integrated care pathway and encourage provision of sustainable holistic solutions in musculoskeletal disorder management.
The musculoskeletal disorder market is expanding in emerging economies due to improving healthcare infrastructure, rising disposable incomes, and increasing awareness. These markets present significant growth opportunities for companies entering with cost-effective and innovative solutions.
Increasing emphasis on patient-centered care and improving quality of life shapes the musculoskeletal disorder market. Therapies that not only address symptoms but also enhance overall well-being gain traction, influencing treatment preferences and market trends.
Musculoskeletal System Disorders Market Highlights:
Musculoskeletal System Disorders Market Forecast
The musculoskeletal system disorders market is expected to reach USD 6.07 Billion by 2032 at 6.8% CAGR during the forecast period 2023-2032.
Musculoskeletal System Disorders Market Synopsis
The number of musculoskeletal system disorder cases is increasing globally, fueling musculoskeletal system disorder market growth. Musculoskeletal system disorders are the second-highest contributor to global disability and an estimated 20%โ33% of people across the globe live with a painful musculoskeletal condition.
Musculoskeletal disorders are most common in low- and middle-income countries and these disorders require lifelong care to manage.
Musculoskeletal System Disorders Market Influencer
Rising prevalence of musculoskeletal disorders and increasing reimbursement offered to patients by health insurance providers.
Musculoskeletal System Disorders Market Drivers
- Growing global geriatric population.
- Change in lifestyle habits leading to bad posture, which is increasing the prevalence of musculoskeletal system disorders.
- Increasing research and development of new drugs to treat musculoskeletal disorders. For instance, in 2017โ2018, the National Institute of Health Research (NIHR) spent approximately USD 13.46 million (GBP 11.1 million) on research on musculoskeletal disorders.
- Rising prevalence of work-related musculoskeletal disorders. For example, the prevalence in the fiscal year 2017โ2018 was about 469,000 in the UK.
- Rising awareness of advanced treatment for musculoskeletal disorders.
- Launch of new medication to manage the symptoms of chronic musculoskeletal system disorders.
Musculoskeletal System Disorders Market Restraints
- High treatment costs.
- Availability of alternative therapies such as traditional medicine and physiotherapy
- Need for specialized equipment to diagnose and treat musculoskeletal system disorders.
Musculoskeletal System Disorders Market Segmentation
By Type
- Rheumatoid Arthritis: The largest segment of the musculoskeletal system disorder market, rheumatoid arthritis afflicts almost 1% of the entire global population and is three times as likely to afflict women than men.
- Osteoarthritis: This disorder generally afflicts elderly people. As of 2018, about 9.6% of men and 18% of women over 60 had symptomatic osteoarthritis worldwide and over a quarter of those afflicted could not perform daily activities.
- Osteoporosis: The fastest-growing segment, over 75 million people suffer from osteoporosis in Europe, the US, and Japan. This number is growing in developing countries and the disorder is responsible for millions of fractures worldwide. By 2050, osteoporosis is expected to be responsible for a 310% increase in hip fractures for men and a 240% increase for women, as compared to rates in 1990.
- Psoriatic Arthritis: This autoimmune disorder afflicts roughly 3 out of every 10 individuals who have psoriasis. With over 100 million people afflicted globally with psoriasis, psoriatic arthritis afflicts almost 30 million individuals.
- Ankylosing Spondylitis: The tendency to develop this condition is genetic, with males twice to three times more likely to be afflicted than women.
- Fibromyalgia: A very common ailment, about 80%โ90% of sufferers of fibromyalgia are women.
- Others: This segment covers musculoskeletal disorders such as tendinitis and carpal tunnel syndrome.
By Treatment
- Biologics: The fastest-growing segment, biologics find increasing application in the treatment of rheumatoid arthritis. A rise in the number of FDA approvals for biologics to treat musculoskeletal system disorders is a key factor for the growth of the segment.
- Corticosteroids: The largest segment, corticosteroids are the preferred treatment for many musculoskeletal system disorders as they reduce inflammation and suppress immune system activity.
- Physical Therapy: Used to manage almost all chronic musculoskeletal system disorders, physical therapy is prescribed in conjunction with medication.
- Extracorporeal Shock Wave Therapy: Used to manage pain, this therapy excels in providing fast-acting relief without the use of painkillers. Used extensively in managing musculoskeletal system disorders.
- Protein Therapy: A novel method used to combat several musculoskeletal system disorders; it involves the ingestion of protein via changes in diet and artificially produced proteins.
- Synthetic Bone Graft: An expensive and complex treatment option, synthetic bone grafts have been used to replace bones made too brittle by osteoporosis and other musculoskeletal system disorders.
- Composite Grafts: Used for several bone replacement and repair procedures.
- Demineralized Bone Matrix: The treatment method is used in bone transplants where the biological activity of the graft is more important than its mechanical properties.
- Others: This segment covers alternative treatment methods such as gene therapy and chiropractic care.
By End User
- Hospitals and Clinics: The largest segment, hospitals and clinics are usually the primary points for diagnosis, treatment, and rehabilitation of individuals afflicted with musculoskeletal system disorders. Growing awareness and increasing efficiency of musculoskeletal system disorder treatment are projected to drive the growth of this segment during the forecast period.
- Ambulatory Surgical Centers: A small segment, these centers provide immediate pain relief and rudimentary surgical care.
- Others: This segment includes home care and senior citizen centers.
By Region
- Americas: The largest regional market, the prevalence of musculoskeletal system disorders is high in the Americas; the region also has a well-established healthcare industry.
- Europe: An increasing geriatric population is leading to a rise in the number of musculoskeletal system disorder cases.
- Asia-Pacific: The fastest-growing regional market, Asia-Pacific is seeing a surge in the number of people afflicted with musculoskeletal system disorders due to bad posture brought on by lifestyle changes, aging, and genetic predisposition.
- Middle East & Africa: The smallest market due to limited healthcare infrastructure and a very young population.
Musculoskeletal System Disorders Market Key Players
- AB Science (France)
- AbGenomics International, Inc. (US)
- Alder BioPharmaceuticals,Inc. (US)
- Amgen Inc. (US)
- Lexicon Pharmaceuticals, Inc. (US)
- LG Chem (South Korea)
- OrthoTrophix, Inc. (US)
- Tarsa Therapeutics, Inc. (US)
- PhytoHealth Corporation (Taiwan)
- Eisai Co., Ltd (Japan)
- Astellas Pharma Inc. (Japan)
- AstraZeneca (UK)
- Baxter (US)
- GlaxoSmithKline PLC (UK)
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
